Ontology highlight
ABSTRACT:
SUBMITTER: Bossi AC
PROVIDER: S-EPMC7547933 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
Bossi Antonio C AC De Mori Valentina V Scaranna Cristiana C Veronesi Giovanni G Lepore Giuseppe G
Diabetes therapy : research, treatment and education of diabetes and related disorders 20200924 11
<h4>Introduction</h4>Dulaglutide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), became available in Italy in April 2016. The aim of ANDREW (Active Notes on Dulaglutide in the REal World), a multicenter, prospective, observational study, was to evaluate glycemic control and weight (co-primary outcomes) for up to 24 months in the real-life setting in consecutive outpatients with type 2 diabetes (T2D) who initiated dulaglutide. Co-secondary outcomes were durability of treatment ...[more]